c[G(2',5')pG(2',5')p](389873-75-0)
- Name: c[G(2',5')pG(2',5')p]
- Synonyms:c[G(2',5')pG(2',5')p];2'-Guanylic acid, guanylyl-(2'→5')-, cyclic 2'→5'''-nucleotide (9CI);Phosphoramidous acid, N,N-bis(1-methylethyl)-, (3R,5S)-5-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-1-[4-[[4-[2-(2-chloro-4-nitrophenyl)diazenyl]phenyl]methylamino]-1-oxobutyl]-3-pyrrolidinyl 2-cyanoethyl ester, rel- (ACI)
- Molecular Formula:C20H24N10O14P2
- Molecular Weight:690.41
- CAS Registry Number:389873-75-0
- EINECS:
- Melting Point:1224.8±75.0 °C(Predicted)
- Water Solubility:
Other Product
- 389570-55-2/Phenol, polymer with formaldehyde, compd. with 2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidine (9CI)
- 389570-79-0/3-Pyridinecarboxamide, N-methoxy-N-methyl-4-(1-methylethyl)-
- 389572-87-6/2: PN: US20040072744 SEQID: 2 claimed protein
- 389572-94-5/Hexanedioic acid, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine, 1,3-butanediol, 1,4-butanediol, 1,6-hexanediol and 1,1'-methylenebis[4-isocyanatocyclohexane] (9CI)
- 389572-95-6/2-Oxepanone, polymer with 1,3-butanediol, 1,2-ethanediol and 1,1'-methylenebis[4-isocyanatocyclohexane] (9CI)
- 38957-46-9/2-(2,4,6-Trimethylbenzenesulfonamido)benzoic acid
- 389625-14-3/2-Naftacencarboxamide, 4-(dimethylamin)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-7-iodo-1,11-dioxo-, (4S,4aS,5aR,12aS)-, mono(trifluoroacetate) (salt)
- 389628-12-0/2(5H)-Pyrimidinone, 4-amino-5-hydroxy- (9CI)
- 38971-42-5/(2R,4S,5R,6R)-2-(2-aminoethoxy)-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
- 38973-29-4/Morphinan, 3-methyl-, (9α,13α,14α)-
- 38974-76-4/2-Hydroxy-1,8-dimethoxyxanthone
- 3897-63-0/1-propan-2-yl-3-prop-2-enylbenzene
- 3898-00-8/N,N-diethyl-5-Methoxy-1,2,3,4-tetrahydronaphthalen-2-aMine hydrochloride
- 389810-97-3/2-(1,3-Benzodioxol-5-ylamino)-2-oxoethyl 2-fluorobenzoate
- 389812-15-1/2-[(4-Ethylphenyl)amino]-2-oxoethyl 2-fluorobenzoate
- 389819-35-6/2-(Benzoyloxy)-N-(2,6-difluorophenyl)acetamide
- 389867-16-7/Cyclosiloxanes, Me hydrogen polymers with vinyl group-terminated di-Me siloxanes
- 389867-93-0/H-Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Lys-Met-PNA
- 389868-12-6/Ac-Glu-Glu-Val-Val-Ala-Cys-PNA
- 389873-75-0/c[G(2',5')pG(2',5')p]
- 389876-48-6/(1E)-N-[4-(morpholin-4-yl)phenyl]-1-(3-phenoxyphenyl)methanimine
- 38998-06-0/4,7-dimethoxy-2,3-dihydro-1H-indene-5-carbaldehyde
- 39005-10-2/Dexamethasone Impurity 19
- 39007-13-1/3-Pyridinecarboxylic acid, 2,5-dimethoxy-, ethyl ester
- 39015-36-6/Chromium, tricarbonyl[(2,3,4,5-η)-tellurophene-κTe]- (9CI)
- 390361-42-9/H-Thr-Thr-PNA
- 390362-78-4/RHPS4
- 390377-79-4/(3R,4R)-3-Hydroxy-4-aminophenylbutyric acid
- 390377-81-8/(3S,4R)-3-Hydroxy-4-aminophenylbutyric acid
- 39037-79-1/2-Propanone, 1-[(2R,3R)-3-methoxy-2-piperidinyl]-, rel-